Candriam Equities L Biotechnology, C - Distribution/ LU0108459552 /
| NAV2024-07-25 | Chg.+8.6300 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 853.2800USD | +1.02% | paying dividend | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2000 | - | - | - | - | 9.07 | 39.65 | -8.01 | 23.69 | 10.72 | -11.24 | -13.74 | 4.18 | - |
| 2001 | -2.63 | -12.28 | -20.64 | 18.86 | 9.28 | 4.98 | -14.90 | 2.77 | -19.22 | 16.98 | 9.78 | 0.03 | -16.11% |
| 2002 | -15.77 | -3.67 | 2.35 | -17.67 | 0.46 | -18.95 | 1.99 | 0.98 | -9.50 | 9.48 | 7.67 | -6.84 | -43.02% |
| 2003 | -4.71 | -4.58 | 6.06 | 7.14 | 20.00 | -3.01 | 7.99 | -2.86 | 2.20 | 2.20 | -1.67 | 6.66 | +38.18% |
| 2004 | 7.08 | 1.56 | -1.42 | -0.39 | -2.54 | -0.01 | -9.09 | 2.22 | 5.78 | -2.11 | 0.82 | 6.14 | +7.16% |
| 2005 | -3.81 | -5.20 | -3.96 | 3.01 | 6.36 | 2.85 | 10.12 | 1.25 | 2.79 | -3.41 | 5.67 | 1.28 | +16.90% |
| 2006 | 6.12 | 3.95 | -3.55 | -4.77 | -4.44 | 0.10 | -2.51 | 2.56 | 0.18 | 13.73 | 0.76 | -2.27 | +8.75% |
| 2007 | 2.28 | -3.54 | 2.02 | 7.47 | 0.08 | -5.87 | -2.83 | 1.87 | 5.50 | 2.14 | -2.82 | -5.94 | -0.65% |
| 2008 | -5.04 | -3.45 | 1.52 | 1.40 | 1.64 | -2.69 | 17.00 | -4.27 | -6.57 | -15.63 | -10.18 | 8.04 | -20.02% |
| 2009 | -1.37 | -7.08 | 6.16 | -0.49 | 2.87 | 7.08 | 29.16 | 2.60 | 1.37 | -11.26 | 7.99 | 5.19 | +44.41% |
| 2010 | 3.27 | 6.32 | 14.94 | -2.02 | -12.51 | -5.73 | 3.62 | -0.48 | 10.70 | 2.68 | -2.59 | 6.17 | +23.65% |
| 2011 | -0.64 | 0.71 | 5.91 | 4.52 | 2.93 | -1.77 | -3.57 | -8.02 | -6.69 | 7.92 | 0.70 | 1.77 | +2.53% |
| 2012 | 11.82 | 0.38 | 5.75 | 0.55 | -2.15 | 5.51 | 2.34 | 1.90 | 5.14 | -5.96 | 4.39 | -1.03 | +31.25% |
| 2013 | 9.66 | 1.02 | 8.07 | 6.09 | 3.28 | -2.76 | 14.25 | -2.44 | 9.93 | -2.81 | 6.52 | 1.60 | +64.40% |
| 2014 | 8.24 | 7.34 | -9.94 | -5.10 | 2.76 | 10.10 | -3.25 | 11.05 | -1.11 | 9.59 | 2.97 | 0.57 | +35.47% |
| 2015 | 4.47 | 4.53 | 1.85 | -5.10 | 10.73 | 0.63 | 4.16 | -10.94 | -11.38 | 7.79 | 3.42 | 0.32 | +8.10% |
| 2016 | -23.25 | -4.59 | 3.67 | 3.77 | 5.58 | -8.41 | 12.55 | -2.39 | 3.96 | -12.73 | 9.10 | -2.85 | -19.51% |
| 2017 | 5.50 | 6.83 | 0.08 | 1.07 | -2.96 | 9.36 | 2.39 | 6.81 | 0.89 | -6.61 | 0.12 | 1.45 | +26.62% |
| 2018 | 6.69 | -4.62 | -2.15 | -3.21 | 4.60 | 0.80 | 4.40 | 4.12 | -2.09 | -14.02 | 4.12 | -8.32 | -11.26% |
| 2019 | 13.12 | 3.56 | -0.58 | -4.95 | -4.48 | 9.42 | -2.22 | -2.37 | -4.52 | 11.18 | 11.96 | 2.77 | +34.92% |
| 2020 | -5.29 | -1.54 | -5.00 | 12.34 | 9.48 | 1.27 | -3.02 | 0.83 | 0.70 | -2.66 | 9.43 | 2.97 | +19.20% |
| 2021 | 1.80 | -2.60 | -4.29 | 2.70 | -2.27 | 6.33 | -1.47 | 3.88 | -4.25 | 0.15 | -4.39 | 2.39 | -2.69% |
| 2022 | -10.59 | -1.56 | 6.03 | -7.24 | -3.98 | 3.49 | 4.70 | 1.52 | -1.91 | 6.49 | 6.17 | -2.88 | -1.52% |
| 2023 | 2.90 | -5.68 | 0.23 | 2.26 | -0.96 | 1.41 | -0.59 | -0.24 | -4.50 | -6.13 | 6.14 | 13.61 | +7.13% |
| 2024 | 1.47 | 1.34 | -0.04 | -6.26 | 3.81 | 5.64 | 6.88 | - | - | - | - | - | - |
Single months: Dividends not considered
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.02% | 16.20% | 16.73% | 20.15% | 22.60% |
| Sharpe ratio | 1.28 | 1.20 | 1.08 | 0.08 | 0.31 |
| Best month | +13.61% | +6.88% | +13.61% | +13.61% | +13.61% |
| Worst month | -6.26% | -6.26% | -6.26% | -10.59% | -10.59% |
| Maximum loss | -11.05% | -11.05% | -12.43% | -28.87% | -30.65% |
| Outperformance | -4.42% | - | -5.67% | +0.19% | -4.92% |
All quotes in USD
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,286.9800 | +22.63% | +17.56% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 243.7100 | +23.94% | +27.10% | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,281.9399 | +20.02% | +9.12% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,456.6499 | +24.63% | +27.49% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,725.7200 | +22.30% | +24.47% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 391.8100 | +22.77% | +28.77% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 360.1900 | +25.10% | +30.50% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 221.7800 | +17.46% | +7.23% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 2,051.3999 | +23.27% | +20.87% | |
| Candriam Equities L Biotechnolog... | reinvestment | 165.2000 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 665.2100 | +21.44% | +15.58% | |
| Candriam Equities L Biotech.I US... | reinvestment | 6,255.2002 | +22.48% | +17.13% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 218.3800 | +19.44% | +8.94% | |
| Candriam Equities L Biotech.R US... | reinvestment | 297.2000 | +22.96% | +19.96% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 228.0600 | +20.44% | +11.65% | |
| Candriam Equities L Biotechnolo... | reinvestment | 934.3600 | +21.88% | +17.02% | |
| Candriam Equities L Biotechnolog... | paying dividend | 853.2800 | +21.84% | +16.91% |
Performance
| YTD | +12.92% | ||
|---|---|---|---|
| 6 Months | +10.97% | ||
| 1 Year | +21.84% | ||
| 3 Years | +16.91% | ||
| 5 Years | +66.24% | ||
| 10 Years | +125.04% | ||
| Since start | +829.41% | ||
| Year | |||
| 2023 | +7.13% | ||
| 2022 | -1.52% | ||
| 2021 | -2.69% | ||
| 2020 | +19.20% | ||
| 2019 | +34.92% | ||
| 2018 | -11.26% | ||
| 2017 | +26.62% | ||
| 2016 | -19.51% | ||
| 2015 | +8.10% | ||
Dividends
| 2024-04-29 | 4.26 USD |
| 2023-04-28 | 3.92 USD |
| 2022-04-28 | 3.44 USD |
| 2021-04-28 | 5.10 USD |
| 2020-04-24 | 2.36 USD |
| 2019-04-26 | 2.90 USD |
| 2018-04-24 | 4.00 USD |
| 2017-04-25 | 2.50 USD |
| 2016-04-26 | 1.76 USD |
| 2015-04-28 | 8.00 USD |
| 2014-04-29 | 0.70 USD |
| 2013-04-26 | 0.70 USD |
| 2012-04-27 | 0.20 USD |
| 2011-04-29 | 0.20 USD |
| 2002-05-13 | 1.00 USD |
